SEMA7A and rheumatoid arthritis: Collectively, these findings demonstrate that Sema7A can strongly elevate the production of inflammatory cytokines, particularly Th17/Tc17 and Th1/Tc1, which is strongly similar to the characteristic cytokine profile of patients with RA displayed by T cells in vitro.